CBAY News and Press, CymaBay Therapeutics Inc. From 06/05/20

NEWARK, Calif., June 05, 2020 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY),  a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that, due to public health and safety...

Shares of CymaBay Therapeutics (NASDAQ: CBAY)  have climbed nearly 143% since last week after it got great news about its orphan drug, seladelpar. A phase 2B trial for the drug to see how it did against nonalcoholic steatohepatitis (NASH, or liver inflammation not caused by alcohol) ha...

Gainers: CymaBay Therapeutics (NASDAQ: CBAY ) +134% . More news on: CymaBay Therapeutics, Inc., Novavax, Inc., Babcock & Wilcox Enterprises, Inc., Stocks on the move, , Read more ...

CymaBay Therapeutics (NASDAQ: CBAY ) +147%  on upgrades  and Q1 results . More news on: CymaBay Therapeutics, Inc., Novavax, Inc., NanoViricides, Inc., News on the U.S. economy Read more ...

"Seledelpar is back," says Raymond James, upgrading CymaBay Therapeutics (NASDAQ: CBAY ) to Outperform after last night's "stunning" news on the treatment. More news on: CymaBay Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Image source: The Motley Fool. CymaBay Therapeutics Inc   (NASDAQ: CBAY) Q1 2020 Earnings Call May 11, 2020 , 4:30 p.m. ET Operator Continue reading

CymaBay Therapeutics, Inc. (CBAY) Q1 2020 Earnings Conference Call May 11, 2020 04:30 PM ET Company Participants Dan Menold - Vice President, Finance Sujal Shah - President and Chief Executive Officer Charles McWherter - Senior Vice President and Chief Scientific Officer Klara ...

CymaBay Therapeutics (NASDAQ: CBAY )  +111.9% after-hours following the company's smaller than forecast Q1 loss and news that an "independent expert panel" unanimously agreed that there is no clinical, biochemical or histological evidence of liver injury induced by its seladelpar liv...

Are These On Your List Of Penny Stocks To Watch This Week? It can be tough at times to trade penny stocks . Some days there are only a few names to choose from. But there are other days where there seems to be plenty of penny stocks to buy . In either case, having your plan in place can defi...

Gainers: CBAY   +73.4% .   NVAX   +42.9% . YRCW   +39.2% . IIVI   +21.5% . BHF   +13.9% . More news on: CymaBay Therapeutics, Inc., Novavax, Inc., YRC Worldwide Inc., Stocks on the move, , Read more ...